SenateS. Rpt. 119-1112026-02-23
RESTORING CONFIDENCE IN THE WORLD ANTI-DOPING AGENCY ACT OF 2025
Summary
S. Rpt. 119-111 accompanies the "Restoring Confidence in the World Anti-doping Agency Act of 2025" — legislation that falls within the Commerce, Science, and Transportation Committee's jurisdiction. Committee reports serve as the official legislative history of a bill, documenting what the legislation would do and why the committee recommends passage. Reports of this kind include the committee's section-by-section analysis, any amendments adopted during markup, the Congressional Budget Office cost estimate, dissenting views from minority members, and the legal basis for the legislation. Courts and agencies consult committee reports when interpreting enacted laws, making these documents important beyond the immediate legislative moment.
Full Text
Official report text. Use Ctrl+F / Cmd+F to search within the document.
Senate Report 119-111 - RESTORING CONFIDENCE IN THE WORLD ANTI-DOPING AGENCY ACT OF 2025
[Senate Report 119-111]
[From the U.S. Government Publishing Office]
Calendar No. 340
119th Congress } { Report
SENATE
2d Session } { 119-111
_______________________________________________________________________
RESTORING CONFIDENCE IN THE WORLD ANTI-DOPING AGENCY ACT OF 2025
__________
R E P O R T
of the
COMMITTEE ON COMMERCE, SCIENCE, AND
TRANSPORTATION
on
S. 233
[GRAPHIC(S) NOT AVAILABLE IN TIFF FORMAT]
February 23, 2026.--Ordered to be printed
______
U.S. GOVERNMENT PUBLISHING OFFICE
69-010 WASHINGTON : 2026
SENATE COMMITTEE ON COMMERCE, SCIENCE, AND TRANSPORTATION
one hundred nineteenth congress
second session
TED CRUZ, Texas, Chairman
JOHN THUNE, South Dakota MARIA CANTWELL, Washington
ROGER F. WICKER, Mississippi AMY KLOBUCHAR, Minnesota
DEB FISCHER, Nebraska BRIAN SCHATZ, Hawaii
JERRY MORAN, Kansas EDWARD J. MARKEY, Massachusetts
DAN SULLIVAN, Alaska GARY C. PETERS, Michigan
MARSHA BLACKBURN, Tennessee TAMMY BALDWIN, Wisconsin
TODD YOUNG, Indiana TAMMY DUCKWORTH, Illinois
TED BUDD, North Carolina JACKY ROSEN, Nevada
ERIC SCHMITT, Missouri BEN RAY LUJAN, New Mexico
JOHN CURTIS, Utah JOHN W. HICKENLOOPER, Colorado
BERNIE MORENO, Ohio JOHN FETTERMAN, Pennsylvania
TIM SHEEHY, Montana ANDY KIM, New Jersey
SHELLEY MOORE CAPITO, West Virginia LISA BLUNT ROCHESTER, Delaware
CYNTHIA M. LUMMIS, Wyoming
Brad Grantz, Majority Staff Director
Lila Harper Helms, Democratic Staff Director
Calendar No. 340
119th Congress } { Report
SENATE
2d Session } { 119-111
=======================================================================
RESTORING CONFIDENCE IN THE WORLD ANTI-DOPING AGENCY ACT OF 2025
----------------
February 23, 2026.--Ordered to be printed
----------------
Mr. Cruz, from the Committee on Commerce, Science, and Transportation,
submitted the following
R E P O R T
[To accompany S. 233]
[Including cost estmate of the Congressional Budget Office]
The Committee on Commerce, Science, and Transportation, to
which was referred the bill (S. 233) to amend the Office of
National Drug Control Policy Reauthorization Act of 2006 to
modify the authority of the Office of National Drug Control
Policy with respect to the World Anti-Doping Agency, and for
other purposes, having considered the same, reports favorably
thereon with an amendment in the nature of a substitute and
recommends that the bill, as amended, do pass.
Purpose of the Bill
The purpose of S. 233 is to require the Office of National
Drug Control Policy (ONDCP) to annually review and determine
whether the World Anti-Doping Agency (WADA) has implemented
certain governance models and reforms. The bill would further
provide ONDCP with the permanent authority to voluntarily
withhold annual dues from WADA if WADA does not meet such
governance models or reforms.
Background and Needs
WADA was established in 1999 as an ``international
independent agency to lead a collaborative worldwide movement
for doping-free sport,'' with its main mission to ensure and
monitor implementation of the World Anti-Doping Code.\1\ WADA
is funded through world governments and the Olympic movement.
Government contributions are calculated via a regional split
agreed upon in 1999, and the Olympic movement matches those
contributions up to 50 percent of WADA's budget.\2\
---------------------------------------------------------------------------
\1\``Who We Are,'' WADA, https://www.wada-ama.org/en/who-we-are;
``What We Do,'' WADA, https://www.wada-ama.org/en/what-we-do.
\2\``Funding,'' WADA, https://www.wada-ama.org/en/who-we-are/
funding.
---------------------------------------------------------------------------
The United States allocates funding to WADA through ONDCP.
ONDCP has been authorized to make financial contributions to
WADA since 2000 through Executive Order 13965.\3\ In 2021,
following frustrations with WADA's handling of the Russian
doping scandal, ONDCP issued a report to Congress that
demonstrated that the United States was not getting its money's
worth for its annual contributions to WADA.\4\ The Subcommittee
on Financial Services and General Government of the Committee
on Appropriations of the Senate has included report language in
appropriations bills, including for fiscal year 2024, that
grants ONDCP the authority and discretion to withhold future
funding in response to WADA's handling of high-profile doping
controversies in Olympic sports.\5\
---------------------------------------------------------------------------
\3\Executive Order 13165 of August 9, 2000, ``Creation of the White
House Task Force on Drug Use in Sports and Authorization for the
Director of the Office of National Drug Control Policy To Serve as the
United States Government's Representative on the Board of the World
Anti-Doping Agency,'' Federal Register 65, no. 157 (2000): 49469-49470,
https://www.federalregister.gov/documents/2000/08/14/00-20670/creation-
of-the-white-house-task-force-on-drug-use-in-sports-and-authorization-
for-the-director-of.
\4\Executive Office of the President Office of National Drug
Control Policy, Report on World Anti-Doping Agency Governance, May 17,
2021, https://www.usada.org/wp-content/uploads/ONDCP-2021-WADA-Report-
to-Congress_Final.pdf.
\5\U.S. Senate Committee on Appropriations, Financial Services and
General Government Appropriations Bill, 2024, Senate Report 118-61,
2023, https://www.congress.gov/congressional-
report/118th-congress/senate-report/61/1.
---------------------------------------------------------------------------
In December 2024, ONDCP withheld payment of the United
States' dues of $3.7 million to WADA as a result of a dispute
with WADA declining to exercise its authority to block Chinese
athletes suspected of doping from competing in the Tokyo
Olympics in 2021.
In January 2021, the Chinese Anti-Doping Agency (CHINADA)
performed drug tests on competitors at a national swim meet--23
of whom tested positive for the PED, Trimetazidine (TMZ).\6\
Three months later, in March, CHINADA reported the positive
tests to WADA.\7\ WADA, however, did not open an investigation
until June 21--6 days after CHINADA issued its determination
that the swimmers had not violated anti-doping rules because
they were ``inadvertently ... exposed to the substance through
food/environment contamination as a result of [Trimetazidine]
detected in the [hotel] kitchen (including spice containers
[and] the extraction fan above the hob and the drains).''\8\
CHINADA did not address how TMZ--a manufactured pharmaceutical
drug that can increase stamina and endurance--popped up in the
spice jars of a commercial kitchen.\9\
---------------------------------------------------------------------------
\6\``Contamination Case of Swimmers From China: Fact Sheet/
Frequently Asked Questions,'' WADA, April 29, 2024, www.wada-ama.org/
sites/default/files/2024-04/2024-04_fact_sheet_faq_
chinese_swimming.pdf; Samuel Joseph, ``Trimetazidine: What Is the
Competition-Banned Drug That Russian Figure Skater Kamila Valieva
Tested Positive For?,'' CNN, January 30, 2024 https://www.cnn.com/2024/
01/30/sport/trimetazidine-what-is-the-competition-banned-drug-that-
russian-figure-skater-kamila-valieva-tested-positive-for/index.html;
Notably, this was not the first time some of those swimmers tested
positive for performance enhancing drugs: the New York Times recently
revealed that three had tested positive for the banned steroid,
clenbuterol, in 2016 and 2017. See Michael S. Schmidt and Tariq Panja,
``Doping Regulator Knew of Previous Positive Tests by Chinese
Swimmers,'' The New York Times, June 14, 2024, https://www.nytimes.com/
2024/06/14/world/asia/china-swimming-doping.html.
\7\Fact Sheet, supra note 7.
\8\Fact Sheet, supra note 7.
\9\Michael S. Schmidt and Tariq Panja, ``Top Chinese Swimmers
Tested Positive for Banned Drug, Then Won Olympic Gold,'' The New York
Times, April 20, 2024, https://www.nytimes.com/2024/04/20/world/asia/
chinese-swimmers-doping-olympics.html.
---------------------------------------------------------------------------
Less than a month after opening an investigation into the
Chinese swimmers, WADA claimed to have ``no basis under the
World Anti-Doping Code to challenge CHINADA's findings of
environmental/food contamination.''\10\ As a result, several of
the Chinese swimmers who tested positive for TMZ not only
competed in the 2021 Olympics, but also won medals, including
three gold medals.\11\
---------------------------------------------------------------------------
\10\Fact Sheet, supra note 7.
\11\Schmidt and Panja, supra note 10.
---------------------------------------------------------------------------
WADA's decision to accept CHINADA's findings stands in
stark contrast to its decision to challenge the Russian Anti-
Doping Agency's initial exoneration of a figure skater who
tested positive for TMZ because of supposed food contamination
less than 6 months later.\12\ The Russian figure skater was
ultimately disqualified from the 2022 Olympic Winter Games and
sanctioned with a 4-year period of ineligibility.\13\
Meanwhile, many of the same Chinese swimmers who tested
positive for TMZ before the 2021 games competed in the Paris
2024 Olympics.\14\
---------------------------------------------------------------------------
\12\``Court of Arbitration for Sport Hands Kamila Valieva Four-Year
Suspension for Anti-Doping Rule Violation,'' Olympics.com, January 30,
2024, https://olympics.com/en/news/court-arbitration-sport-kamila-
valieva-four-year-suspension-anti-doping-rule-violation.
\13\Ibid.
\14\Janie McCauley, ``Olympic Swimmers Speak Out About Chinese
Doping; and Britain's Adam Peaty Says They Should Be Out,'' AP, August
4, 2024, https://apnews.com/article/
chinese-doping-olympics-2024-swimming-21d41f66a2d3cc6e7d8e506ac7872ffa.
---------------------------------------------------------------------------
On June 17, 2025, the Commerce Committee's Subcommittee on
Consumer Protection, Technology, and Data Privacy held a
hearing titled ``WADA Shame: Swimming in Denial Over Chinese
Doping.'' One of the witnesses was an Olympic silver medalist
who competed against a winning Chinese team at the Tokyo
Olympics and testified to the challenges of an uneven playing
field for athletes. Another witness, Travis Tygart, chief
executive officer of the U.S. Anti-Doping Agency (USADA), spoke
on the insufficiency of WADA's explanations for accepting
CHINADA's findings and in favor of restricting dues from the
United States until WADA enacts reforms. Dr. Rahul Gupta,
former Director of ONDCP, spoke about the importance of
withholding funds unless WADA enacts reforms to level the
playing field for athletes. WADA was invited to testify but
declined. WADA also declined to testify at a hearing held by
the Subcommittee on Oversight and Investigations of the
Committee on Energy and Commerce of the House of
Representatives in June 2024.
This bill would give ONDCP the voluntary power to withhold
the U.S. annual dues payment to WADA if they do not enact
necessary governance reforms to keep U.S. athletes on an even
playing field with their international competitors.
Summary of Provisions
S. 233 would do the following:
Require ONDCP, in consultation with USADA, the
United States Olympic and Paralympic Committee, and the
Athlete's Advisory Council, to annually determine
whether WADA has met specific reform criteria,
including the implementation of governance reforms to
ensure both independent governance and fair
representation of the United States as well as the
establishment of fair process and procedures to select
independent athletes for decision-making roles.
Permit ONDCP, in consultation with Congress, to
voluntarily withhold up to the full amount of any funds
made available for the payment of the United States
membership due to WADA if ONDCP determines WADA has not
met the reform criteria laid out above. Any funds
withheld would be required to be returned to the
general fund at the end of the applicable fiscal year,
unless otherwise specified by law.
In the case of a determination that WADA is not
meeting the above reform criteria, require ONDCP, in
consultation with USADA, the United States Olympic and
Paralympic Committee, and the Athlete's Advisory
Council, to file a report to Congress describing the
barriers to participation and fair representation of
the United States on WADA's Executive Committee and
other decision-making bodies within WADA if the ONDCP
decides to withhold funds.
Require ONDCP to submit a spending plan to the
appropriate committees of Congress along with an
explanation of proposed uses of the funds.
Legislative History
S. 233 was introduced on January 23, 2025, by Senator
Blackburn (for herself and Senators Van Hollen, Capito,
Blumenthal, and Wicker) and was referred to the Committee on
Commerce, Science, and Transportation of the Senate. Senators
Blunt Rochester and Lujan were later added as cosponsors. On
June 25, 2025, the Committee met in open Executive Session and,
by voice vote, ordered S. 233 reported favorably with an
amendment (in the nature of a substitute).
118th Congress
S. 4839, the Restoring Confidence in the World Anti-Doping
Agency Act of 2024, was introduced on July 30, 2024, by Senator
Blackburn (for herself and Senator Van Hollen) and was referred
to the Committee on Commerce, Science, and Transportation of
the Senate. Senator Blumenthal was later added as a cosponsor.
Estimated Costs
In accordance with paragraph 11(a) of rule XXVI of the
Standing Rules of the Senate and section 403 of the
Congressional Budget Act of 1974, the Committee provides the
following cost estimate, prepared by the Congressional Budget
Office:
[GRAPHIC(S) NOT AVAILABLE IN TIFF FORMAT]
S. 233 would require the Office of National Drug Control
Policy (ONDCP), in consultation with the U.S. Olympic and
Paralympic Committee and the Athletes' Advisory Council, to
report on activities of the World Anti-Doping Agency (WADA).
Specifically, ONDCP would determine whether WADA has an
independent governance model, is making appropriate reforms,
and has fair processes to include athletes in decisionmaking or
advisory roles who are unaffiliated with any Olympic Committee
or WADA. The legislation also would permit ONDCP to
unilaterally withhold dues from WADA for noncompliance with
those criteria.
Each year, the Congress appropriates funds for ONDCP for
anti-doping activities and to pay U.S. membership dues to WADA.
(In 2024, the United States. withheld its dues payment of $3.6
million.) Because the legislation would not significantly
change current authorities, policies, or practices, CBO
estimates that implementing S. 233 would cost less than
$500,000 over the 2025-2030 period for administrative costs.
Any related spending would be subject to the availability of
appropriated funds.
The CBO staff contact for this estimate is Matthew
Pickford. The estimate was reviewed by H. Samuel Papenfuss,
Deputy Director of Budget Analysis.
Phillip L. Swagel,
Director, Congressional Budget Office.
Regulatory Impact Statement
In accordance with paragraph 11(b) of rule XXVI of the
Standing Rules of the Senate, the Committee provides the
following evaluation of the regulatory impact of the
legislation, as reported:
number of persons covered
S. 233, as reported, would set requirements for ONDCP. S.
233 would require ONDCP to submit a spending plan to the
appropriate authorizing committees with an explanation of the
proposed uses of the funds they request as well as a report if
ONDCP decides to withhold annual dues from WADA. Additionally,
WADA could be impacted by S. 233, to the extent ONDCP chooses
to withhold funds pursuant to the Act.
economic impact
S. 233 is not expected to have an adverse impact on the
Nation's economy.
privacy
S. 233 is not expected to have an impact on the personal
privacy of individuals.
paperwork
S. 233 would require the ONDCP to file a report to Congress
that describes the barriers to participation and fair
representation of the United States on WADA's Executive
Committee and other decision-making bodies within WADA.
Congressionally Directed Spending
In compliance with paragraph 4(b) of rule XLIV of the
Standing Rules of the Senate, the Committee provides that no
provisions contained in the bill, as reported, meet the
definition of congressionally directed spending items under the
rule.
Section-by-Section Analysis
Section 1. Short title.
This section would provide that the Act may be cited as the
``Restoring Confidence in the World Anti-Doping Agency Act of
2025''.
Section 2. Authority of National Drug Control Policy with respect to
the World Anti-Doping Agency.
This section would amend the Office of National Drug
Control Policy Reauthorization Act of 2006 to add new
definitions for the terms ``amateur athlete'', ``amateur
athletic competition'', ``independent athlete'', and ``United
States Olympic and Paralympic Committee''.
This section would also require ONDCP, in consultation with
the United States Anti-Doping Agency, the United States Olympic
and Paralympic Committee, and the Athletes' Advisory Council,
to make an annual determination as to whether WADA meets the
following criteria:
Has a credible and independent governance model that
provides for fair representation of the United States;
Fully implements or has implemented governance
reforms to ensure independent governance; and
Has fair processes and procedures to select
independent athletes, including athletes from the
United States and other democratic countries (or their
representatives), for decisionmaking roles within WADA.
In the event WADA cannot meet these criteria, this section
would (1) require ONDCP to use all available tools to bring
WADA into compliance with such criteria; and (2) file a report
to Congress that describes the barriers to participation and
fair representation of the United States on WADA's Executive
Committee and other decision-making bodies within WADA.
This section would also permit ONDCP, in the event WADA
cannot meet the above criteria, to voluntarily withhold up to
the full amount of any funds made available for the payment of
the United States membership dues to WADA. This section would
further provide that any funds withheld would be required to be
returned to the general fund at the end of the applicable
fiscal year, unless otherwise specified by law.
This section would require that if ONDCP were to obligate
funds to WADA, it would need to submit a spending plan to the
appropriate committees of Congress along with an explanation of
how WADA meets the above criteria.
Finally, this section would define the appropriate
committees of Congress as the Committee on Commerce, Science,
and Transportation of the Senate; the Committee on
Appropriations of the Senate; the Committee on Energy and
Commerce of the House of Representatives; and the Committee on
Appropriations of the House of Representatives.
Changes in Existing Law
In compliance with paragraph 12 of rule XXVI of the
Standing Rules of the Senate, changes in existing law made by
the bill, as reported, are shown as follows (existing law
proposed to be omitted is enclosed in black brackets, new
material is printed in italic, existing law in which no change
is proposed is shown in roman):
OFFICE OF NATIONAL DRUG CONTROL POLICY
REAUTHORIZATION ACT OF 2006
* * * * * * *
TITLE VII--ANTI-DOPING AGENCY
[21 U.S.C. 2001; Public Law 117-103]
SEC. 701. DESIGNATION OF UNITED STATES ANTI-DOPING AGENCY.
[(a) Definitions.--In this title:
[(1) United states olympic committee.--The term
``United States Olympic Committee'' means the
organization established by the ``Ted Stevens Olympic
and Amateur Sports Act'' (36 U.S.C. 220501 et seq.).
[(2) Amateur athletic competition.--The term
``amateur athletic competition'' means a contest, game,
meet, match, tournament, regatta, or other event in
which amateur athletes compete (36 U.S.C.
220501(b)(2)).
[(3) Amateur athlete.--The term ``amateur athlete''
means an athlete who meets the eligibility standards
established by the national governing body or
paralympic sports organization for the sport in which
the athlete competes (36 U.S.C. 22501(b)(1)).]
(a) Definitions.--In this subchapter:
(1) Amateur athlete.--The term ``amateur athlete''
has the meaning given that term in section 220501(b)(1)
of title 36, United States Code.
(2) Amateur athletic competition.--The term ``amateur
athletic competition'' has the meaning given that term
in section 220501(b)(2) of title 36, United States
Code.
(3) Independent athlete.--The term ``independent
athlete'' means a current or former amateur athlete who
does not serve, in any capacity--
(A) on the International Olympic Committee;
(B) on the International Paralympic
Committee;
(C) at an international sports federation
recognized by the International Olympic
Committee or the International Paralympic
Committee;
(D) on the United States Olympic and
Paralympic Committee;
(E) at a national governing body (as defined
in section 220501(b)(9) of title 36, United
States Code); or
(F) at the World Anti-Doping Agency.
(4) United states olympic and paralympic committee.--
The term ``United States Olympic and Paralympic
Committee'' means the organization established by
chapter 2205 of title 36, United States Code.
(b) In General.--The United States Anti-Doping Agency shall--
(1)(A) serve as the independent anti-doping
organization for the amateur athletic competitions
recognized by the United States Olympic and Paralympic
Committee;
(B) be responsible for certifying in advance any
testing conducted by international organizations under
the World Anti-Doping Code for international amateur
athletes and athletic competitions occurring within the
jurisdiction of the United States; and
(C) be recognized worldwide as the independent
national anti-doping organization for the United
States;
(2) ensure that athletes participating in amateur
athletic activities recognized by the [United States
Olympic Committee] United States Olympic and Paralympic
Committee are prevented from using performance-
enhancing drugs or prohibited performance-enhancing
methods adopted by the Agency;
(3) implement anti-doping education, research,
testing, and adjudication programs to prevent United
States Amateur Athletes participating in any activity
recognized by the [United States Olympic Committee]
United States Olympic and Paralympic Committee from
using performance-enhancing drugs or prohibited
performance-enhancing methods adopted by the Agency;
(4) serve as the United States representative
responsible for coordination with other anti-doping
organizations coordinating amateur athletic
competitions recognized by the [United States Olympic
Committee] United States Olympic and Paralympic
Committee to ensure the integrity of athletic
competition, the health of the athletes, and the
prevention of use by United States amateur athletes of
performance-enhancing drugs or prohibited performance-
enhancing methods adopted by the Agency; and
(5) promote a positive youth sport experience by
using a portion of the funding of the United States
Anti-Doping Agency to provide educational materials on
sportsmanship, character building, and healthy
performance for the athletes, parents, and coaches who
participate in youth sports.
(c) Due Process in Arbitration Proceedings.--Any action taken
by the United States Anti-Doping Agency to enforce a policy,
procedure, or requirement of the United States Anti-Doping
Agency against a person with respect to a violation of Federal
law, including an investigation, a disciplinary action, a
sanction, or any other administrative action, shall be carried
out in a manner that provides due process protection to the
person.
(d) Authority With Respect to the World Anti-Doping Agency.--
(1) Annual determination.--Not later than 180 days
after the date of the enactment of this subsection, and
annually thereafter, the Office of National Drug
Control Policy, in consultation with the United States
Anti-Doping Agency, the United States Olympic and
Paralympic Committee, and the Athletes' Advisory
Council (established and maintained under section
220504(b)(2)(A) of title 36, United States Code) shall
make a determination as to whether the World Anti-
Doping Agency--
(A) has a credible and independent governance
model that provides for fair representation of
the United States;
(B) fully implements or has implemented
governance reforms to ensure independent
governance; and
(C) has fair processes and procedures to
select independent athletes, including athletes
from the United States and other democratic
countries, or representatives of such athletes,
for decision-making roles on the Executive
Committee and the Foundation Board, and in all
relevant expert advisory groups, standing
committees, permanent special committees, and
working groups of the World Anti-Doping Agency.
(2) Accountability.--In the case of a determination
under paragraph (1) that the World Anti-Doping Agency
has not met the criteria set forth in subparagraphs
(A), (B), or (C) of that paragraph, the Office of
National Drug Control Policy, in consultation with the
United States Anti-Doping Agency, the United States
Olympic and Paralympic Committee, and the Athletes'
Advisory Council (established and maintained under
section 220504(b)(2)(A) of title 36, United States
Code), shall use all available tools and best efforts
to bring the World Anti-Doping Agency into compliance
with the criteria set forth in that paragraph.
(3) Report.--In the case of a determination under
paragraph (1) that the World Anti-Doping Agency has not
met the criteria set forth in subparagraphs (A), (B),
or (C) of that paragraph, not later than 180 days after
the date on which that determination is made, the
Office of National Drug Control Policy, in consultation
with the United States Anti-Doping Agency, the United
States Olympic and Paralympic Committee, and the
Athletes' Advisory Council (established and maintained
under section 220504(b)(2)(A) of title 36, United
States Code) shall submit to the appropriate committees
of Congress a report that describes the barriers to
participation and fair representation of the United
States on the Executive Committee, the Foundation
Board, and all relevant expert advisory groups,
standing committees, permanent special committees, and
working groups of the World Anti-Doping Agency.
(4) Voluntary nonpayment of dues.--
(A) In general.--In the case of a
determination under paragraph (1) that the
World Anti-Doping Agency has not met the
criteria set forth in subparagraphs (A), (B),
or (C) of that paragraph, the Office of
National Drug Control Policy, in consultation
with the appropriate committees of Congress,
may voluntarily withhold up to the full amount
of any funds made available for the payment of
the United States membership dues to the World
Anti-Doping Agency.
(B) Return of funds after noncompliance.--
Unless otherwise specified by law, any funds
made available for the payment of the United
States membership dues to the World Anti-Doping
Agency that have been voluntarily withheld
pursuant to subparagraph (A) and have not been
obligated prior to the end of an applicable
fiscal year shall be returned to the general
fund of the Treasury.
(5) Spending plan.--Not later than 30 days before the
Office of National Drug Control Policy obligates funds
to the World Anti-Doping Agency, the Office of National
Drug Control Policy shall submit to the appropriate
committees of Congress a spending plan and explanation
of proposed uses of such funds.
(6) Appropriate committees of congress defined.--In
this subsection, the term `appropriate committees of
Congress' means--
(A) the Committee on Commerce, Science, and
Transportation of the Senate;
(B) the Committee on Appropriations of the
Senate;
(C) the Committee on Energy and Commerce of
the House of Representatives; and
(D) the Committee on Appropriations of the
House of Representatives.
* * * * * * *
[all]